Development and Validation of Bioanalytical Method for Simultaneous Estimation of Tenofovir Disoproxil Fumarate, Lamivudine and Efavirenz in Formulation by Advanced Derivative Uv-spectroscopy
Year: 2025
Type: article
Abstract: A selective and sensitive derivative spectrophotometry method was developed to detect and quantify tenofovirdisoproxilfumarate, lamivudine and efavirenz in rat plasma. After liquid-liquid extraction the analyte were analysed. Mixture of methanol and phosphate buffer pH.5.0 (60:50 v/v) was used as solvent. The method was based on the measurement of absorbance at zero crossing points of three drugs 260.8nm, 271nm, and 247.6 nm respectively. The method was validated according to USFDA guidelines over the range of 100-3200 ng/mL for tenofovirdisoproxilfumarate and lamivudine and 200-6400ng/mL for efavirenz, with correlation coefficient values (R2) 0.999 for tenofovirdisoproxilfumarate and efavirenz, and 0.997 for lamivudine. The absolute recovery for analyte achieved from spiked plasma sample was consistent and reproducible. The % CV reported for precision and accuracy determinations across four validation runs (LLOQ, LQC, MQC and HQC) were less than 15. LLOQ was found to be 100ng/mL for tenofovirdisoproxilfumarate and lamivudine and 200ng/mL for efavirenz. Keywords: TenofovirDisoproxilFumarate, Lamivudine, Efavirenz, Derivative Spectrophotometry, BioanalyticalMethod Validation, USFDA guidelines.
Authors: CH. Naveen Kumar*, K. Ajay Kumar, P. Jyothi, Namra Shaikh, U. Jashwa, Y. Praneeth, Dr. A. Madhukar
Language: English
Subfield: Analytical Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7101898170
FWCI:
Cites:
Cited by:
Related to: